Universitat de Barcelona (UB) / University of Barcelona

A Social Innovation Serious Game for Higher Education (2022) Schorer A, Pouliopoulos T, Garefi I, Kalemaki I, Galvan C, Barajas M, Theodoridou K, et al. Conference contribution, Abstract of lecture Metal-Support Interaction and Charge Distribution in Ceria-Supported Au Particles Exposed to CO (2022) Bezkrovnyi O, Bruix A, Blaumeiser D, Piliai L, Schötz S, Bauer T, Khalakhan I, et al. Journal article The nature and chronology of human occupation at the Galerias Bajas, from Cueva de Ardales, Malaga, Spain (2022) Ramos-Munoz J, Cantalejo P, Blumenröther J, Bolin V, Otto T, Rotgaenger M, Kehl M, et al. Journal article Quantum gravity phenomenology at the dawn of the multi-messenger era—A review (2022) Addazi A, Alvarez-Muniz J, Alves Batista R, Amelino-Camelia G, Antonelli V, Arzano M, Asorey M, et al. Journal article, Review article New Oldowan localities at high level within Kilombe Caldera, Kenya De nouvelles localités oldowayennes à un niveau élevé dans la caldeira de Kilombe, au Kenya (2022) Gowlett JA, Stanistreet IG, Albert RM, Blackbird SJ, Herries AI, Hoare S, Kogai P, et al. Journal article The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma (2022) Cathomas R, Lorch A, Bruins HM, Compérat EM, Cowan NC, Efstathiou JA, Fietkau R, et al. Journal article, Review article Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity (2021) Hanna BS, Llao-Cid L, Iskar M, Roessner PM, Klett LC, Wong JKL, Paul Y, et al. Journal article Cereblon enhancer methylation and IMiD resistance in multiple myeloma (2021) Haertle L, Barrio S, Munawar U, Han S, Zhou X, Vogt C, Fernandez RA, et al. Journal article 2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde (2021) Musto P, Engelhardt M, Caers J, Bolli N, Kaiser M, Van De Donk N, Terpos E, et al. Journal article, Review article New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension (2021) Stone JH, Spotswood H, Unizony SH, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Journal article